Current space

Members

Filtered creator directory for "deangelis".

Directory 201.5K Indexed posts 43M Verified 0
Active AuthorsRecent indexed creators Registered MembersAccount directory Completed ProfilesProfiles with public details VerifiedTrusted member signals
201.5KActive members
43MIndexed posts
286KDetailed profiles
21Sources in this view

Active authors

Showing directory results matching your search with real activity counts for visible profiles.

Page 1 | 20 shown
A
Money worries plague biotech insiders ahead of JPM week
Money worries plague biotech insiders ahead of JPM week
Adam Feuerstein, Allison DeAngelis avatar
@Adam Feuerstein, Allison DeAngelis
Adam Feuerstein,
Feb 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Money worries plague biotech insiders ahead of JPM week
statnews.com
0Following 0Comments 0Views 0Shares
A
Expert analyzes potential new pancreatic cancer breakthrough
Readout LOUD podcast: Moderna, the FDA, and Vinay Prasad
How Trump's presidency could affect biotech, FDA regulation, and more
Expert analyzes potential new pancreatic cancer breakthrough
Adam Feuerstein, Allison DeAngelis, Elaine Chen avatar
@Adam Feuerstein, Allison DeAngelis, Elaine Chen
Adam Feuerstein,
Apr 20, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 4Posts 1Sources 0Reputation
Latest signal 0 reactions
Expert analyzes potential new pancreatic cancer breakthrough
statnews.com
0Following 0Comments 0Views 0Shares
A
Readout LOUD podcast: Sarepta's Duchenne gene therapy halt
Readout LOUD podcast: sickle cell treatment woes and GLP-1 outlook | STAT
Readout LOUD podcast: JPM 2026 to bring more deals, happy CEOs
Readout LOUD podcast: Sarepta's Duchenne gene therapy halt
Adam Feuerstein, Elaine Chen, Allison DeAngelis avatar
@Adam Feuerstein, Elaine Chen, Allison DeAngelis
Adam Feuerstein,
Feb 7, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 3Posts 1Sources 0Reputation
Latest signal 0 reactions
Readout LOUD podcast: Sarepta's Duchenne gene therapy halt
statnews.com
0Following 0Comments 0Views 0Shares
A
Biotech raises $42 million to run Huntington’s disease trial | STAT
Johnson & Johnson's IBD therapy fails to yield meaningful improvement | STAT
Veradermics’ hair loss drug succeeds in late-stage trial | STAT
Biotech raises $42 million to run Huntington’s disease trial | STAT
Allison DeAngelis avatar
@Allison DeAngelis
Allison DeAngelis
May 6, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 34Posts 1Sources 0Reputation
Latest signal 0 reactions
Biotech raises $42 million to run Huntington’s disease trial | STAT
statnews.com
0Following 0Comments 0Views 0Shares
A
Readout LOUD podcast: Obesity drug side effects, CDC nominee testifies| STAT
Readout LOUD podcast: Obesity drug side effects, CDC nominee testifies| STAT
Allison DeAngelis, Adam Feuerstein avatar
@Allison DeAngelis, Adam Feuerstein
Allison DeAngelis,
Feb 1, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Readout LOUD podcast: Obesity drug side effects, CDC nominee testifies| STAT
statnews.com
0Following 0Comments 0Views 0Shares
A
A biotech VC explains what Eli Lilly saw in a struggling cancer startup for $3.2B
The Readout LOUD: Better IBD treatments and FDA questions | STAT
Readout LOUD podcast: ASH recap, the future of American science | STAT
A biotech VC explains what Eli Lilly saw in a struggling cancer startup for $3.2B
Allison DeAngelis, Adam Feuerstein, Elaine Chen avatar
@Allison DeAngelis, Adam Feuerstein, Elaine Chen
Allison DeAngelis,
Apr 25, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 6Posts 1Sources 0Reputation
Latest signal 0 reactions
A biotech VC explains what Eli Lilly saw in a struggling cancer startup for $3.2B
statnews.com
0Following 0Comments 0Views 0Shares
A
Nonprofit launches with $500M to modernize scientific process for AI era
Nonprofit launches with $500M to modernize scientific process for AI era
Allison DeAngelis, Brittany Trang avatar
@Allison DeAngelis, Brittany Trang
Allison DeAngelis,
Mar 12, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
Nonprofit launches with $500M to modernize scientific process for AI era
statnews.com
0Following 0Comments 0Views 0Shares
A
Readout LOUD podcast: Biotech VCs face China, AI challenges | STAT
New weight loss drugs vying to be the next Wegovy or Mounjaro
Wegovy, Zepbound and weight loss drugs that preserve muscle
Readout LOUD podcast: Biotech VCs face China, AI challenges | STAT
Allison DeAngelis, Elaine Chen avatar
@Allison DeAngelis, Elaine Chen
Allison DeAngelis,
Apr 13, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 4Posts 1Sources 0Reputation
Latest signal 0 reactions
Readout LOUD podcast: Biotech VCs face China, AI challenges | STAT
statnews.com
0Following 0Comments 0Views 0Shares
A
Readout LOUD podcast: A CAR-T biotech's dramatic turnaround
Epstein pal attempts a biotech comeback and Vinay Prasad exits FDA | STAT
Readout LOUD podcast: Biotech's year in review
Readout LOUD podcast: A CAR-T biotech's dramatic turnaround
Allison DeAngelis, Elaine Chen, Adam Feuerstein avatar
@Allison DeAngelis, Elaine Chen, Adam Feuerstein
Allison DeAngelis,
Apr 25, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 3Posts 1Sources 0Reputation
Latest signal 0 reactions
Readout LOUD podcast: A CAR-T biotech's dramatic turnaround
statnews.com
0Following 0Comments 0Views 0Shares
A
Next-generation blood thinner from Bristol Myers Squibb, J&J fails key trial
Two entrepreneurs try to upend the biotech funding model
Next-generation blood thinner from Bristol Myers Squibb, J&J fails key trial
Allison DeAngelis, Matthew Herper avatar
@Allison DeAngelis, Matthew Herper
Allison DeAngelis,
Feb 7, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 2Posts 1Sources 0Reputation
Latest signal 0 reactions
Next-generation blood thinner from Bristol Myers Squibb, J&J fails key trial
statnews.com
0Following 0Comments 0Views 0Shares
A
How data integrity issues roiled Laronde, seen as ‘Moderna 2.0’
How data integrity issues roiled Laronde, seen as ‘Moderna 2.0’
Allison DeAngelis, Ryan Cross — The Boston Globe avatar
@Allison DeAngelis, Ryan Cross — The Boston Globe
Allison DeAngelis,
May 3, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
How data integrity issues roiled Laronde, seen as ‘Moderna 2.0’
statnews.com
0Following 0Comments 0Views 0Shares
C
Maryland’s Assault on Private Education | The Heritage Foundation
Supreme Court Rules Against Schools Keeping Secrets From Parents | The Heritage Foundation
Kentucky Legislature Overrides Beshear Veto To Join Trump School-Choice Program | The Heritage Foundation
Maryland’s Assault on Private Education | The Heritage Foundation
Corey DeAngelis avatar
@Corey DeAngelis
Corey DeAngelis
Apr 11, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 9Posts 2Sources 0Reputation
Latest signal 0 reactions
Maryland’s Assault on Private Education | The Heritage Foundation
heritage.org
0Following 0Comments 0Views 0Shares
C
More school choice means more school safety
More school choice means more school safety
Corey DeAngelis and martin-lueken avatar
@Corey DeAngelis and martin-lueken
Corey DeAngelis
Jan 29, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
More school choice means more school safety
washingtonexaminer.com
0Following 0Comments 0Views 0Shares
C
School Choice Teaches Iowa Republicans a Big Lesson | The Heritage Foundation
School Choice Teaches Iowa Republicans a Big Lesson | The Heritage Foundation
Corey DeAngelis, PhD avatar
@Corey DeAngelis, PhD
Corey DeAngelis,
Feb 2, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 1Posts 1Sources 0Reputation
Latest signal 0 reactions
School Choice Teaches Iowa Republicans a Big Lesson | The Heritage Foundation
heritage.org
0Following 0Comments 0Views 0Shares
D
Readout LOUD podcast: mifepristone case, GLP-1s, & Chinese biotech
Readout LOUD podcast: Vertex's big deal, biotech's red numbers | STAT
Readout LOUD podcast: mifepristone case, GLP-1s, & Chinese biotech
Damian Garde, Allison DeAngelis, Adam Feuerstein avatar
@Damian Garde, Allison DeAngelis, Adam Feuerstein
Damian Garde,
Feb 7, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 2Posts 1Sources 0Reputation
Latest signal 0 reactions
Readout LOUD podcast: mifepristone case, GLP-1s, & Chinese biotech
statnews.com
0Following 0Comments 0Views 0Shares
E
Readout LOUD podcast: biotech investors' plea to Trump
Readout LOUD podcast: FDA's gene therapy turmoil
Readout LOUD podcast: measles outbreak and hospitals' financials
Readout LOUD podcast: biotech investors' plea to Trump
Elaine Chen, Adam Feuerstein, Allison DeAngelis avatar
@Elaine Chen, Adam Feuerstein, Allison DeAngelis
Elaine Chen,
Apr 3, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 3Posts 1Sources 0Reputation
Latest signal 0 reactions
Readout LOUD podcast: biotech investors' plea to Trump
statnews.com
0Following 0Comments 0Views 0Shares
E
Biotechs aim to leapfrog Ozempic in red-hot weight loss market
Obesity drug tracker: Can amylin drugs upend Wegovy, Zepbound? | STAT
Biotechs aim to leapfrog Ozempic in red-hot weight loss market
Elaine Chen, Allison DeAngelis avatar
@Elaine Chen, Allison DeAngelis
Elaine Chen,
Jan 28, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 2Posts 1Sources 0Reputation
Latest signal 0 reactions
Biotechs aim to leapfrog Ozempic in red-hot weight loss market
statnews.com
0Following 0Comments 0Views 0Shares
H
16th Annual Lustgarten Foundation NYC Walk for Pancreatic Cancer Research raises critical funds - CBS New York
NYC Council passes bill to study reparations for slavery - CBS New York
"Tripledemic" of flu, COVID and RSV cases surging across New York ahead of holidays, health officials warn - CBS New York
16th Annual Lustgarten Foundation NYC Walk for Pancreatic Cancer Research raises critical f...
https://twitter.com/jennamdeangelis avatar
@https://twitter.com/jennamdeangelis
Https://twitter.com/jennamdeangelis User
Apr 20, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 17Posts 1Sources 0Reputation
Latest signal 0 reactions
16th Annual Lustgarten Foundation NYC Walk for Pancreatic Cancer Research raises critical funds - CBS New York
cbsnews.com
0Following 0Comments 0Views 0Shares
H
More School Choice, Less Crime | Cato at Liberty Blog
The Evidence on School Choice Is Far from "Mixed" | Cato Institute
More School Choice, Less Crime | Cato at Liberty Blog
https://www.cato.org/people/corey-deangelis avatar
@https://www.cato.org/people/corey-deangelis
Https://www.cato.org/people/corey-deangelis User
Apr 13, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 2Posts 1Sources 0Reputation
Latest signal 0 reactions
More School Choice, Less Crime | Cato at Liberty Blog
cato.org
0Following 0Comments 0Views 0Shares
J
Jennifer Doudna biotech Azalea Therapeutics raises $82 million | STAT
Scientist on Baby KJ team launches new CRISPR startup | STAT
Jennifer Doudna biotech Azalea Therapeutics raises $82 million | STAT
Jason Mast, Allison DeAngelis avatar
@Jason Mast, Allison DeAngelis
Jason Mast,
Feb 7, 2026
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers 2Posts 1Sources 0Reputation
Latest signal 0 reactions
Jennifer Doudna biotech Azalea Therapeutics raises $82 million | STAT
statnews.com
0Following 0Comments 0Views 0Shares